Fed. Circ. Won't Rethink Corcept Patent Loss In Teva Case
Corcept Therapeutics Inc. lost its bid Friday to have the full Federal Circuit look at a panel's refusal to revive its suit accusing Teva Pharmaceuticals USA Inc. of patent infringement over...To view the full article, register now.
Already a subscriber? Click here to view full article